Write in a clean editor, then format for Future Pharmacology in one click — DocuGuru applies the official MDPI template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Future Pharmacology is a peer-reviewed journal published by MDPI, covering Computational Drug Discovery Methods, Essential Oils and Antimicrobial Activity, Neuroscience and Neuropharmacology Research. Over its lifetime it has published 263 papers, which have received 1,576 citations.
| Publisher | MDPI |
|---|---|
| Reference style | Numbered (MDPI) Numbered — [1], [2] in the text 1. Smith, A.; Jones, B.; Lee, C. A Representative Article Title. Future Pharmacology 2023, 12, 45–58.
Formats any DOI in Future Pharmacology style. No sign-up. |
| Abbreviation (ISO-4) | Future Pharmacol. |
| Publishes research in | Computational Drug Discovery Methods Essential Oils and Antimicrobial Activity Neuroscience and Neuropharmacology Research Pharmacogenetics and Drug Metabolism Phytochemicals and Antioxidant Activities |
| ISSN | 2673-9879 |
| Citation impact (2-yr) | 2.82 |
| h-index | 19 |
| i10-index | 42 |
| Open access | Yes — indexed in DOAJ |
| Top institutions publishing here | Universidade do Porto |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
The struggle between humans and pathogens has taken and is continuing to take countless lives every year. As the misusage of conventional antibiotics increases, the complexity associated with the resistance mechanisms of pathogens has been evolving into gradually more clever mechanisms, diminishing the effectiveness of antibiotics. Hence, there is a growing interest in discovering novel…
In the 21st century, plant-derived metal nanoparticles (PDMNPs) have gained considerable interest because of their tremendous and remarkable potential as therapeutic agents as well as development of less expensive, safer, and easier biomedical equipment. PDMNPs are synthesized from metal salts or oxides by using plant extracts because plants have diversified bioactive compounds that can act…
This work reports on a complex in silico assessment of the ADME properties of Salubrinal (S1) and 54 of its structural analogues containing a cinnamic acid residue (S2–S40) or a quinoline ring (S41–S55). In the work for (Q)SAR forecast, the online servers SwissADME, ADMETlab, admetSAR 2.0, Molinspiration, ALOGPS 2.1, pkCSM, SuperCYPsPred, and Vienna LiverTox were…
Alzheimer’s disease (AD) is a progressive, multifactorial, and unremitting neurodegenerative disease characterized by memory loss, personality changes, and cognitive impairment. It has become more prevalent in recent years. Therefore, understanding the pathophysiology of AD and developing efficient therapeutic strategies are essential. Moreover, the progression of the disease is unaffected by the pharmaceutical approaches discovered to…
Glycyrrhizic acid (GA) is the main active component of the licorice root, which has been known in traditional medicine since the ancient times. It is a molecule composed of a hydrophilic part, two glucuronic acid molecules, and a hydrophobic part, glycyrrhetinic acid. GA, when subjected to acid hydrolysis, releases 18β- and 18α-glycyrrhetinic acids. Glycyrrhetinic acid…
